Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: An open-label pilot study

Research output: Contribution to journalArticlepeer-review

261 Scopus citations

Fingerprint

Dive into the research topics of 'Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: An open-label pilot study'. Together they form a unique fingerprint.

Medicine & Life Sciences